Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Caligiuri

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Seminars in Oncology|December 1, 1993
Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applicationsM A Caligiuri
Seminars in Oncology|August 19, 2000
Acquired immunodeficiency syndrome-related lymphomas: future directionsP Porcu, M A Caligiuri
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 1, 1998
Interleukin-15 as a potential regulator of the innate immune responseW Carson, M A Caligiuri
Seminars in Oncology|October 1, 1989
Pregnancy and leukemiaM A Caligiuri, R J Mayer
Current Opinion in Oncology|January 1, 1997
Developments in cytogenetics and oncogenes in acute leukemiaM P Strout, M A Caligiuri
Blood|January 3, 2001
Interleukin 15: biology and relevance to human diseaseT A Fehniger, M A Caligiuri
Leukemia|April 18, 2002
Immunologic manipulation in AML: from bench to bedsideM A Cooper, M A Caligiuri
Blood|February 1, 1997
Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune responseM E Ross, M A Caligiuri
International Reviews of Immunology|March 7, 2002
Ontogeny and expansion of human natural killer cells: clinical implicationsT A Fehniger, M A Caligiuri
Cancer Immunology, Immunotherapy : CII|August 5, 1998
A review of the association between interleukin-10 and human B-cell malignanciesV P Khatri, M A Caligiuri
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Seminars in Oncology|December 1, 1993
Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applicationsM A Caligiuri
Seminars in Oncology|August 19, 2000
Acquired immunodeficiency syndrome-related lymphomas: future directionsP Porcu, M A Caligiuri
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 1, 1998
Interleukin-15 as a potential regulator of the innate immune responseW Carson, M A Caligiuri
Seminars in Oncology|October 1, 1989
Pregnancy and leukemiaM A Caligiuri, R J Mayer
Current Opinion in Oncology|January 1, 1997
Developments in cytogenetics and oncogenes in acute leukemiaM P Strout, M A Caligiuri
Blood|January 3, 2001
Interleukin 15: biology and relevance to human diseaseT A Fehniger, M A Caligiuri
Leukemia|April 18, 2002
Immunologic manipulation in AML: from bench to bedsideM A Cooper, M A Caligiuri
Blood|February 1, 1997
Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune responseM E Ross, M A Caligiuri
International Reviews of Immunology|March 7, 2002
Ontogeny and expansion of human natural killer cells: clinical implicationsT A Fehniger, M A Caligiuri
Cancer Immunology, Immunotherapy : CII|August 5, 1998
A review of the association between interleukin-10 and human B-cell malignanciesV P Khatri, M A Caligiuri
Pageof 13